Ezarmia Tablets 100mg, from Daiichi Sankyo, contains Valemetostat Tosilate (YJ code: 4291079F2022, standard: 100mg 1 tablet). This medication is a dual inhibitor of EZH1 and EZH2, epigenetic regulators crucial for gene expression and implicated in various cancers. By reducing H3K27 methylation, it reactivates tumor suppressor genes, thereby inhibiting cancer cell proliferation.
Ezarmia Tablets 100mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
